DNASE1 and systemic lupus erythematosus: They found that sera from SLE patients were not as able to effectively degrade NETs as controls, which they hypothesized could be due to the presence of DNase1 inhibitors or obstructive anti-NET antibodies which could prevent substrate binding [13].